Clinical TrialsSearch results
Number of results: 261
Other
- Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
- High risk myelodysplastic syndrome and MDS/secondary AML
- Japan Adult Leukemia Study Group
- 2006-04-17
Other
- Phase 2 study of imatinib-combined chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia (JALSG Ph+ALL202)
- Acute lymphoblastic leukemia
- Japan Adult Leukemia Study Group
- 2005-08-17
Other
- Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
- Acute Lymphoblastic Leukemia
- Tokyo Children's Cancer Study Group
- 2008-10-05
Recruiting
- Phase I clinical study on the safety of HER2-specific chimeric antigen receptor (CAR) gene-modified T cell therapy
- HER2 positive osteosarcoma/soft tissue sarcoma and gynecologic malignancy
- Yozo Nakazawa
- 2022-05-25
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- Phase II clinical trial of advanced stage ymphoblastic lymphoma. A Japanese Pediatric Cooperative Study
- Advanced stage lymphoblastic lymphoma of children.
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Phase II clinical trials of mature B-cell neoplasms in children: A Japanese Cooperative Studies
- mature B-cell non-Hodgkin's lymphoa
- Japanese Pediatric Leukemia/Lymphoma Studu Group(JPLSG)
- 2006-02-05
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10
Recruiting
- Phase II Study of Amrubicin and Nitroglycerin in Third-Line Chemotherapy in Previously Treated Patients with Non-Small-Cell Lung Cancer
- Previously treated non-small-cell lung cancer
- Division of Clinical Trial Design and Management, Translational Clinical Center, Kyoto University Hospital
- 2007-09-12